Healthcare Advisors and Regulatory Risk: How Healthcare CEOs De-Risk Licensing and Compliance
Healthcare Advisors and Regulatory Risk: How Healthcare CEOs De-Risk Licensing and Compliance Key Takeaways Why Regulatory Risk Becomes a Valuation Discount in Healthcare Deals Buyers pay premiums for certainty, not hope. When compliance evidence is thin, they respond with escrow, special indemnities, and tighter representations. Use Negotiating Reps & Warranties to explain how terms […]
Read MoreHealthcare CEO Guide: Handling Accounts Receivable and Working Capital in Smaller Deals
Healthcare CEO Guide: Handling Accounts Receivable and Working Capital in Smaller Deals Key Takeaways Why A/R Becomes a Deal Term In smaller practice transactions, buyers aren’t only buying EBITDA—they’re buying the ability to convert revenue into cash. If collections are slow or A/R quality is unclear, buyers protect themselves with working-capital targets, holdbacks, or post-close […]
Read More
